Open for inclusion

Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers

Cancer type: Solide tumores

Phase: II

Principal Investigator: Lassen Ulrik

Country: DK

Keywords: Denmark, Rigshospitalet, BRAFV600E mutation, rare cancers

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02034110?term=Mutated+Rare+Cancers+with+Several+Histologies&rank=1